See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI102.44▲ 2.99%
← HAVAS page
XStocksXray
Market X-Ray report · 22 October 2026

HAVAS SA (HAVAS)

Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026

Key indicators

Last closeEUR 17.10
52-week range12.83 – 20.10
Return, 1 month / 3 months−5.0% / −7.1%
Return, 1 year / 3 years+21.2% / –
TrendAbove 200-day, below 50-day
RSI (14)36
Volatility (1 year)29.7%
Worst drawdown (1 year)-21.6%
Average daily value traded1.45M EUR
Dividend yield4.7%

Market X-Ray price-based

56/ 100 · High confidence · ahead of 54% of stocks on this exchange
Trend65
Momentum58
Stability (higher is calmer)58
Liquidity48
Income36

Five-year price chart navy: price · brown: 200-day average

9.9812.4414.9017.3719.832024-122025-062025-112026-052026-10

About the company

Havas is a communications and advertising group based in France. It provides advertising, media planning and buying, public relations, digital marketing and design services to clients across many industries. Its agencies work with brands on campaigns, content and customer communications in markets around the world. The company operates through a network of specialist agencies and offices serving businesses that need marketing and communication support.

HAVAS SA trades under the code HAVAS on the Euronext Amsterdam in Netherlands, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

HAVAS SA (HAVAS) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 17.10 on 22 October 2026.

Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 51 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 21.2% and over the last three months it fell 7.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
HAVAS SA (HAVAS)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam

Lens and metricValueScoreReading
Trend65 · FairMixed trend against its averages.
Above 200-day average1.8%
From 52-week high-11.4%
Momentum58 · FairTypical recent returns for this exchange.
3-month return-7.1%
6-month return10.3%
12-month return, skipping the last month27.6%
Stability (higher is calmer)58 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)29.7%
Worst drawdown, 1 year (smaller is calmer)-21.6%
Liquidity48 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded1.45M EUR
Zero-volume days0.0%
Income36 · WeakDividend is small or irregular.
Dividend yield4.7%
Years with dividends2

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.
  • Income: Dividend is small or irregular.

Returns

1 week−4.5%
1 month−5.0%
3 months−7.1%
6 months+10.3%
1 year+21.2%
3 years–
5 years–

Signals

50-day / 200-day average18.05 / 16.79
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.44

Technical summary

DailyBearish5 bullish · 1 neutral · 10 bearish
WeeklyBearish2 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish4 bullish · 1 neutral · 0 bearish

Recent dividends

Ex-dividend dateAmount per share
15 May 2026EUR 0.8000
30 May 2025EUR 0.0800

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026